Crizotinib
Crizotinib (PF-02341066; PF-2341066) is a potent, selective, orally bioavailable, ATP-competitive inhibitor of c-Met catalytic activity with Ki of 4 nM.
Product Specifications
CAS Number
877399-52-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
450.3367
Molecular Formula
C21H22Cl2FN5O
Notes
Research use only, not for human use.
Receptor
ALK|c-Met
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
M2350-02F-HRP 100 µL
MAP2 (Microtubule Associated Protein 2, MAP-2) (HRP)
Sign In for Pricing
View Details 
245827-APC 100 µL
ERN1 (Endoplasmic Reticulum to Nucleus Signaling 1, FLJ30999, IRE1, IRE1P, MGC163277, MGC163279) (APC)
Sign In for Pricing
View Details 254208 50 µL
OVCA1 (Candidate Tumor Suppressor in ovarian cancer 1, Diphthamide biosynthesis Protein 1, Diphthamide biosynthesis Protein 2 Homolog like 1, Diphthamide biosynthesis Protein 2 like, Diptheria toxin resistance Protein required for diphthamide biosynthesis (Saccharomyces) like 1, Diptheria toxin resistance Protein required for diphthamide biosynthesis like 1, DPH like 1 (S.cerevisiae), DPH like 1, DPH1, DPH1 Homolog (S. cerevisiae), DPH1 Homolog, DPH2 like 1, DPH2L, DPH2L1, FLJ33211, HsDph1, Ovariancancer Associated gene 1, Ovarian cancer Associated gene 1 Protein, Ovarian Tumor Suppressorcandidate 1) (Not for Export EU)
Sign In for Pricing
View Details